XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ DEFICIT - USD ($)
$ in Millions
Total
Bausch Health Companies Inc. Shareholders’ Deficit
Common Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Non- controlling Interest
Beginning Balance (in shares) at Dec. 31, 2023     365,200,000        
Beginning Balance at Dec. 31, 2023 $ (82) $ (1,022) $ 10,423 $ 214 $ (9,778) $ (1,881) $ 940
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     1,500,000        
Common shares issued under share-based compensation plans 0   $ 57 (57)      
Share-based compensation 33 33   33      
Employee withholding taxes related to share-based awards (14) (14)   (14)      
Vesting of B+L equity compensation 0 (12)   (12)     12
Net loss (77) (64)     (64)   (13)
Other comprehensive income (loss) (34) (36)       (36) 2
Ending Balance (in shares) at Mar. 31, 2024     366,700,000        
Ending Balance at Mar. 31, 2024 $ (174) (1,115) $ 10,480 164 (9,842) (1,917) 941
Beginning Balance (in shares) at Dec. 31, 2024 367,843,058   367,800,000        
Beginning Balance at Dec. 31, 2024 $ (322) (1,279) $ 10,490 234 (9,824) (2,179) 957
Increase (Decrease) in Shareholders' Equity              
Common shares issued under share-based compensation plans (in shares)     1,700,000        
Common shares issued under share-based compensation plans 0   $ 18 (18)      
Share-based compensation 43 43   43      
Employee withholding taxes related to share-based awards (16) (16)   (16)      
Vesting of B+L equity compensation 0 (23)   (23)     23
Net loss (86) (58)     (58)   (28)
Other comprehensive income (loss) $ 141 150       150 (9)
Ending Balance (in shares) at Mar. 31, 2025 369,539,455   369,500,000        
Ending Balance at Mar. 31, 2025 $ (240) $ (1,183) $ 10,508 $ 220 $ (9,882) $ (2,029) $ 943